Market Cap

Ascendis Pharma A/S Market Capitalization:

$7.09 Billion

USD as of Jan. 1, 2023

business Ascendis Pharma A/S Company Profile

Ascendis Pharma A/S Main Stock Listing

show_chart NASDAQ: ASND

Market Capitalization History of Ascendis Pharma A/S

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Ascendis Pharma A/S market cap

Date Market Cap YoY Change
Jan. 1, 2023 $7.09 B 4.23%
Jan. 1, 2022 $6.80 B -18.99%
Jan. 1, 2021 $8.40 B 11.14%
Jan. 1, 2020 $7.56 B 89.06%
Jan. 1, 2019 $4.00 B 40.20%
Jan. 1, 2018 $2.85 B 137.73%
Jan. 1, 2017 $1.20 B 12.61%
Jan. 1, 2016 $1.07 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Ascendis Pharma A/S Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Ascendis Pharma A/S has the following listings and related stock indices.


Stock: NASDAQ: ASND

Stock: Bovespa: A1SN34

Stock: FSX: A71

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.